Stocks · News reference

AN2 Therapeutics, Inc. Reports Inducement Grants Under Listing Rule 5635(c)(4)

Oct 24, 2026, 1:03 PM

AN2 Therapeutics, Inc. announced the grant of inducement equity awards to two newly hired employees.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

Fiscal.aiOct 21, 2026, 1:04 PM
AN2 Therapeutics to Present Phase 2 Trial Design for Epetraborole in Polycythemia Vera
AN2 Therapeutics announced it will present the design of its planned Phase 2 clinical trial for epetraborole in patients with polycythemia vera at the 18th International Congress on Myeloproliferative Neoplasms.
ANTX
Fiscal.aiOct 21, 2026, 1:04 PM
AN2 Therapeutics to Participate in Upcoming Investor Conferences
AN2 Therapeutics announced its upcoming participation in investor conferences.
ANTX
BenzingaOct 21, 2026, 11:07 AMBenzinga Newsdesk
AN2 Therapeutics To Present Planned Phase 2 Trial Design For Epetraborole In Polycythemia Vera On October 29
ANTX